Inactive Instrument

News Cancer Genetics, Inc.

Equities

CGIX

US13739U2033

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cancer Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Cancer Genetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Cancer Genetics : Vyant Bio Presentation – April 2021	21-04-06	PU
Cancer Genetics and StemoniX Announce Merger Closing	21-03-31	GL
CANCER GENETICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	21-03-31	AQ
Cancer Genetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-31	CI
Cancer Genetics, Inc. has Changed its Ticker to VYNT from CGIX	21-03-31	CI
Cancer Genetics, Inc. has Changed its Name to Vyant Bio, Inc	21-03-30	CI
Cancer Genetics, Inc.(NasdaqCM:CGIX) dropped from NASDAQ Composite Index	21-03-30	CI
StemoniX Inc. completed the acquisition of Cancer Genetics, Inc. from a group of shareholders in a reverse merger transaction.	21-03-29	CI
Cancer Genetics : Secures Shareholder Nod for Proposed StemoniX Merger	21-03-25	MT
CANCER GENETICS, INC : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	21-03-25	AQ
Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX	21-03-25	GL
Cancer Genetics : Announces Roland J. Carrillo, PhD as Vice President of Business Development	21-03-18	AQ
Cancer Genetics, Inc. Appoints Roland J. Carrillo as the Vice President of Business Development	21-03-18	CI
CANCER GENETICS, INC : Other Events (form 8-K)	21-03-16	AQ
Cancer Genetics to Present at the Annual 33rd ROTH Conference	21-03-12	GL
Cancer Genetics : Company Presentation Q1 2021	21-03-05	PU
Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference	21-03-04	GL
CANCER GENETICS, INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	21-02-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cancer Genetics, Inc.

Equities

CGIX

US13739U2033

Summary

Filters